Health & Biotech
Check out the latest Medtech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
Optiscan inks deal with US uni to diagnose cancer in animals
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Health & Biotech
BlinkLab rises on positive results of autism study
Health & Biotech
EBR reports milestone quarter, final FDA review for WiSE CRT system
Health & Biotech
BlinkLab joins ‘landmark’ Monash University autism/ADHD project
Health & Biotech
Optiscan inks deal with Monash Uni to progress GI scope
Health & Biotech
Dr Boreham’s Crucible: Can this cancer drug developer hit right notes for commercial success?
Health & Biotech
Basement to Breakthrough: Imricor transforms heart treatment with MRI
Stockhead TV
Long Shortz with Optiscan: OIL targets massive US veterinary market at major healthcare events
Stockhead TV
Long Shortz with Orthocell: Nerve repair product ready for US domination on $17M raise
Health & Biotech
Dr Boreham’s Crucible: Can this nuclear medicine play’s tech explode in the US?
Stockhead TV
Long Shortz with Aroa Biosurgery: Puzzle pieces coming together for success in H2 FY25
Health & Biotech
EBR seeks key WiSE US reimbursement
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Biocurious: Optiscan aims for cancer surgery to be done right all the time, first time
Health & Biotech
Imricor eyes worldwide expansion with progress on US and EU regulatory approval
Health & Biotech
LTR Pharma’s ED treatment SPONTAN outperforms with 470% faster absorption
Health & Biotech
HeraMED revolutionising maternity care with digital technology
Health & Biotech
Health Check: Thirsty Chimeric goes to the well for funding top-up
Stockhead TV
Break it Down: AdAlta moves into a higher realm of drug development with new advisory board
Stockhead TV
Long Shortz with Lumos Diagnostics: Attention from the globe as antimicrobial resistance takes flight
Stockhead TV
Long Shortz with Orthocell: Gateway to Asia open with Singapore market entry
Health & Biotech
Health Check: Fresh from its FDA win, Echo IQ aims for even bigger heart failure approval
Health & Biotech
Biocurious: With Singaporean approval ticked off, Orthocell eyes the crucial US nerve-repair market
Health & Biotech
User base expands for HeraMED’s remote pregnancy monitoring platform
Health & Biotech
Orthocell secures regulatory approval to launch Remplir sales in Singapore
Health & Biotech
Lodge Partners sees 430% upside for Blinklab, developer of smartphone autism test
Health & Biotech
‘Closer to US commercialisation’ – EBR achieves major FDA milestone
Health & Biotech
Health Check: Probiotics supplier has gut feeling about surging growth
Stockhead TV
Long Shortz with PharmAust: Sweet incentives for sad disease’s drug development
Health & Biotech
EBR begins $50m capital raise to commercialise WiSE leadless pacemaker
Health & Biotech
Bio Curious: How Dimerix negotiates the ‘valleys of death’ on the winding road to drug approval
Stockhead TV
Long Shortz with EBR Systems: regulatory submission a major milestone
Health & Biotech
‘Significant milestone’ – EBR submits final PMA module to FDA
Health & Biotech
Lumos Diagnostics seals deal to advance point-of-care test to monitor liver health
Health & Biotech
CBL lifts on NeuroNode’s approval as reimbursable medical device in US
Health & Biotech
Optiscan joins with US uni to improve cancer detection in animals
Health & Biotech
Curvebeam’s “weight-bearing CT scanner” to gain more traction after FDA clearance
Health & Biotech
First US patient treated in Imricor cardiac ablation trial
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Health & Biotech
NorthStar sees good impact in Control Bionics, invests $525k
Health & Biotech
BlinkLab partners with Mental Care Group to advance ADHD diagnostics in Europe
Stockhead TV
Break it Down: Optiscan Imaging to transform digital pathology
Health & Biotech
Imricor Medical Systems raising $35m to fund growth strategy
Health & Biotech
Vital Signs Podcast: Optiscan
Health & Biotech
Orthocell to sell Striate+ in Canada after regulatory approval
Health & Biotech
Investors are all ears as Orthocell’s nerve and tissue solutions deliver record revenue
Load More